吉林敖東(000623.SZ):公司有多種用於流感病毒預防、流感治療、退燒的藥品
格隆匯2月27日丨吉林敖東(000623.SZ)在投資者互動平台表示,公司有多種用於流感病毒預防、流感治療、退燒的藥品。“小兒柴桂退熱口服液” 作為中藥退熱藥物,功能主治為:發汗解表,清裏退熱。用於小兒外感發熱。症見:發熱,頭身痛,流涕,口渴,咽紅,溲黃,便幹。目前“小兒柴桂退熱口服液”已經被納入多個臨牀指南推薦使用,在臨牀應用中更是有着“治癒率高、複發率低、治療週期短、退熱平穩不反彈”等具體表現。公司聚焦兒科領域,打造以“小兒柴桂退熱口服液”、“羚貝止咳糖漿”等退熱止咳臨牀領域優勢品種,形成重點品種、潛力品種梯隊發展多品種羣。圍繞以“小兒柴桂退熱口服液”為核心的退熱止咳類眾多品種,銷售收入實現穩步增長。2024年2月20日,公司通過研發獲得用於甲型和乙型流感治療藥品“磷酸奧司他韋膠囊”45mg、30mg、75mg三個規格,進一步豐富公司產品種類,增強了公司核心競爭力,為公司穩步發展創造了有利條件。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.